Publication: Community pharmacy-based implementation and evaluation of an Osteoporosis Self-Assessment Tool for Asians
Issued Date
2006-01-01
Resource Type
ISSN
15443450
15443191
15443191
Other identifier(s)
2-s2.0-33745122970
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of the American Pharmacists Association. Vol.46, No.3 (2006), 391-396
Suggested Citation
Nathorn Chaiyakunapruk, Ampuscha Laowakul, Saree Karnchanarat, Nisakorn Pikulthong, Boonsong Ongphiphadhanakul Community pharmacy-based implementation and evaluation of an Osteoporosis Self-Assessment Tool for Asians. Journal of the American Pharmacists Association. Vol.46, No.3 (2006), 391-396. doi:10.1331/154434506777069624 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/23269
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Community pharmacy-based implementation and evaluation of an Osteoporosis Self-Assessment Tool for Asians
Other Contributor(s)
Abstract
Objectives: To implement an osteoporosis screening and referral program in community pharmacies and evaluate the use of the Osteoporosis Self-Assessment Tool for Asians (OSTA) as the screening instrument. Design: Uncontrolled study. Setting: Three community pharmacies in Bangkok, Thailand. Patients: 51 women aged 50 years or older without prior diagnosis of osteoporosis; three community pharmacists; six hospital-based physicians. Intervention: OSTA assessment by community pharmacists of the risks of osteoporosis in patients; counseling of patients about diet and exercise; referral of patients at high risk (OSTA index value less than -4) to hospitals where pharmacists had made arrangements in advance; and assessment of satisfaction and opinions of participating patients and physicians. Results: Of the 51 patients, 32 (62.7%) were categorized as low risk (OSTA index value > -1) and 19 (37.3%) as intermediate risk (OSTA index value range, -4 to -1). The majority of patients (97%) were satisfied with the program and the knowledge gained. Even though no high-risk patients were identified and referred for medical care, all six participating physicians agreed with having risk assessment service in community pharmacies and the prearranged referral system, and five of six physicians believed that OSTA results were valuable in the management of osteoporosis. Conclusion: Community pharmacy-based osteoporosis risk assessment services using OSTA were well accepted by the patients and participating physicians. Public health benefits may result from the provision of osteoporosis risk screening services in community pharmacies in Thailand and other Asian countries.